The Institute of Genetic Engineering and Biotechnology for Postgraduate Studies at the University of Baghdad organized a scientific symposium titled:
“Bacteriophage Therapy as an Alternative to Antibiotics: Efficacy and Safety in Clinical Applications.”
The symposium was conducted by Dr. Ali Mohammed Redha Al-Fandi, with Dr. Zahraa Ahmed Shakir serving as the session chair and Assistant Lecturer Rand Qusay Majid as the session rapporteur. The event was attended by a distinguished group of professors, faculty members, and students of the institute.
The symposium aimed to highlight the role of bacteriophages as a promising alternative to antibiotics, demonstrating their ability to target and eliminate bacterial infections.
The symposium discussed a Bacteriophage therapy has proven effective against antibiotic-resistant pathogens and can also help reduce side effects by selectively targeting specific bacteria. Despite its potential, challenges remain, including the need for customized treatments and comprehensive clinical validation to ensure the safety and widespread adoption of bacteriophage therapy.
The symposium emphasized the importance of addressing these challenges to facilitate the clinical implementation and regulatory approval of bacteriophage-based treatments.
